|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 02713093.9 (espacenet) (Federated) (European Patent Register), 20020321 | Patent/reg. no. and date | DK/EP 1478355, 20070307 | Publication date | 20041124 | Priority no. and date | US 813018, 20010321 | EP pub. no. and date |
EP 1478355 20041124 | Effective date | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92165 Antony Cédex, FR | Applicant ref. no. | AVENT ST92072A | Inventor | BISSERY, Marie-Christine, 5, rue Henri-Poincaré
F-94400 Vitry-sur-Seine, FR | Representative | | Opponent | | IPC Class | A61K 31/337 (2006.01) , A61P 35/00 (2006.01) | Title | Antitumorsammensætninger, som indeholder taxanderivater | Int. application no. | IB2002000853 | Int. publication no. | WO2002074289 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |